Patents (1287 Stem Cell Patents)

Method of enhancing neural stem cell proliferation, differentiation, and...

Pharmaceutical activation of stem cells is arguably the next major revolution in medicine. The current patent is assigned to a Canadian stem cell company, Stem Cell Therapeutics (TSX-V:SSS), which already has entered Phase II clinical trials with pharmaceutical activators of endogenous stem cells for the treatment of stroke. While the ongoing clinical work of Stem Cell Therapeutics involves administration of erythropoietin and human chorionic gonadotrophin for activation of endogenous neural stem cells, the current patent covers the use of a peptide hormone for a similar purpose... [Read more]

LATEST STEM CELL PATENTS

Three dimensional bioengineered smooth muscle tissue and sphincters and...

4 days ago

This patent covers methods of producing artificial sphincters.  Specifically, smooth muscle cells are grown on an extracellular matrix that is placed on a tissue culture vessal coated with polydimethyl siloxane and a mold made of a cylindrical shape which is coated with the same material.  Examples of extracellular matrices useful for the invention include fibrin.  The patent covers a variety of sphincters including internal anal and sphincters of the gastrointestinal tract.

Sphincter repair is currently in clinical trials from several companies, including the French... [Read more]

Multi-lineage directed induction of bone marrow stromal cell...

May 3rd

This patent covers a 2 step method of generating insulin producing cells.

According to the first issued claim, the initial step involves obtaining what essentially appears to be a mesenchymal stem cell (adherent cell positive for CD44, CD90 and CD71, negative for monocyte and hematopoietic markers, CD11b and CD45, respectively) and culturing them with an antioxidant in order to generate an endodermal/neuronal precursor cell, said cell is then differentiated in the second step to an insulin producing cell by culture in basic fibroblast growth factor. The second claim covers... [Read more]

Loop peptide and TGF.alpha. for stimulating stem cell proliferation and...

May 3rd

Stem cells need to be maintained in a quiescent state when they are not needed to make new cells.  This is because if stem cells were consistently proliferating then there would be a high propability of mutations, thus leading to cancer.  One of the methods that stem cells maintain themselves in a non-proliferating state is through autocrine secretion of inhibitory factors.  One such main autoinhibitory factors is Transforming Growth Factor (TGF)-beta.  This is why patents, such as US patent #6627191 cover the use of neutralizing... [Read more]

View all stem cell patents

RECENTLY ADDED STEM CELL PATENTS
Patents added 5 days ago. Patents added May 3rd. Patents added April 27th. Patents added April 26th. Patents added April 20th. Patents added April 13th. Patents added April 6th. Patents added April 5th. Patents added March 30th. Patents added March 23rd. Patents added March 16th. Patents added March 15th. View all 1287 stem cell patents





Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2008 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.01